IMLYGIC is a live, attenuated type I herpes simplex virus (HSV-1), that has been genetically engineered in order to express GM-CSF, replicate and lyse tumor cells and enhance immune response by antigen presenting cells [136]. Here, CSF2 is linked to neoplasm.